Comparison of Pain Scores in Postoperative Patients: Intravenous Morphine Patient-Controlled Analgesia vs Iontophoretic Transdermal Fentanyl.
Postoperative management of pain has traditionally utilized intravenous (IV) morphine for pain control. An alternative approach to the invasive patient-controlled analgesia (PCA) system is the administration of transdermal analgesics, such as fentanyl. In 2006 the Food and Drug Administration (FDA) approved the fentanyl hydrochloride (fentanyl HCl) iontophoretic transdermal system (ITS), which utilizes iontophoretic technology to produce a controlled electrical current that propels ionized fentanyl molecules into the systemic vasculature. Transdermal fentanyl has been shown to be equivalent or superior to IV morphine PCA in a variety of postoperative settings with patients experiencing decreased pain scores and a favorable side effect profile.
University of Central Florida College of Medicine, University of Central Florida College of Medicine, Orlando, FL.
Gabriel D
GD
Glaun
University of Central Florida College of Medicine, University of Central Florida College of Medicine, Orlando, FL.
Anthony M
AM
Caram
University of Central Florida College of Medicine, University of Central Florida College of Medicine, Orlando, FL.
Nirav
N
Patel
University of Central Florida College of Medicine, University of Central Florida College of Medicine, Orlando, FL.
Hayden M
HM
Sandler
fentanyl; iontophoretic transdermal system; morphine; orthopedic surgery; pain-controlled analgesia; postoperative pain control; surgery
Anesthesiology. 1995 May;82(5):1146-53
7741289
J Pharm Pharmacol. 2001 Jun;53(6):769-77
11428652
Br J Anaesth. 2007 Jun;98(6):806-15
17519263
J Opioid Manag. 2016 Jan-Feb;12(1):37-45
26908302
Anesth Analg. 1997 Mar;84(3):509-14
9052292
Pain Manag. 2015 Sep;5(5):339-48
26088721
Anesth Analg. 2003 Aug;97(2):534-40, table of contents
12873949
Br J Anaesth. 2007 Jan;98(1):4-11
17158126
Paediatr Anaesth. 1999;9(5):419-22
10447905
JAMA. 2004 Mar 17;291(11):1333-41
15026400
Pain Med. 2007 Nov-Dec;8(8):657-68
18028044